drugset / Trial / NCT07036796
Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the current study is to measure the effect of melatonin as adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in type 2 diabetic patients with diabetic peripheral neuropathy.
Timeline
- Start
- 2025-07-04
- Primary completion
- 2026-07-04
- Completion
- 2026-07-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 10 mg | — |